These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4213816)

  • 41. Primary drug resistance of mycobacteria tuberculosis in Taiwan.
    Wu YT
    Taiwan Yi Xue Hui Za Zhi; 1973 Mar; 72(3):135-42. PubMed ID: 4634133
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibiotics, antiseptics and tubercle bacilli.
    McDonald PJ; Murray CJ; McDonald HM
    Med J Aust; 1974 Jul; 2(2):41-5. PubMed ID: 4212945
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative determinations of Mycobacterium resistance using the vertical diffusion test and the proportion method (economical test)].
    Kalich R; Nitschke M; Ulber H; Mydlak G; Werner E; Gerloff W; Reinhold L
    Z Erkr Atmungsorgane; 1974; 140(3):242-52. PubMed ID: 4142152
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of tuberculosis. The Mitchell lecture 1979.
    Mitchison DA
    J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
    [No Abstract]   [Full Text] [Related]  

  • 45. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
    Uttley AH; Collins CH
    Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 48. Analysis of metabolic changes in revertants of antibiotic-resistant micobacteria.
    Alberghina M; Palermo F
    Boll Ist Sieroter Milan; 1975; 54(6):445-7. PubMed ID: 177028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 51. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 53. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    Lai CC; Tan CK; Huang YT; Liao CH; Hsueh PR
    J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
    Eltringham IJ; Wilson SM; Drobniewski FA
    J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 56. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
    Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of primary resistance to antitubercular drugs in Galicia].
    Alvarez D; Valle JM; Martino MV; Gordo P; Carreira J; Valdés L
    Arch Bronconeumol; 1994; 30(6):297-300. PubMed ID: 8087389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 60. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
    Tousek J; Jancik E; Zelenka M; Jancikova-Máková M
    Tubercle; 1967 Mar; 48(1):27-31. PubMed ID: 4291925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.